CIAM
VIVS

Caitong International Asset Management’s VivoSim Labs VIVS Stock Holding History

Caitong International Asset Management’s Portfolio VIVS Stock Details VIVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4 Buy
+3
New +$6 ﹤0.01% 2362

Other funds holding VIVS

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
AF
Allworth Financial Folsom, California $24.7B AUM 15.55% 1-Year Est. Return

Caitong International Asset Management's VIVS Position: Q1 2026 in Review

Caitong International Asset Management opened a new position in VivoSim Labs (VIVS) in Q1 2026: 3 shares worth $4. The stake represents ﹤0.01% of the portfolio and ranks #2362 among its holdings.

24 funds tracked by Wall St. Rank hold VIVS as of Q1 2026.

  • Caitong International Asset Management held 3 shares of VivoSim Labs worth $4 as of Q1 2026.
  • VivoSim Labs was a new Caitong International Asset Management position in Q1 2026.
  • VivoSim Labs made up ﹤0.01% of Caitong International Asset Management's portfolio in Q1 2026, its #2362 holding.
  • 24 funds tracked by Wall St. Rank held VivoSim Labs as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.